| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |